Total Payments
$190,316
2024 Payments
$41,354
Companies
43
Transactions
707
Medicare Patients
2,667
Medicare Billing
$772,877
Payment Breakdown by Category
Other$121,630 (63.9%)
Travel$31,451 (16.5%)
Consulting$21,802 (11.5%)
Food & Beverage$15,026 (7.9%)
Education$366.28 (0.2%)
Gifts$40.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,055 | 35 | 36.3% |
| Honoraria | $52,575 | 26 | 27.6% |
| Travel and Lodging | $31,451 | 126 | 16.5% |
| Consulting Fee | $21,802 | 9 | 11.5% |
| Food and Beverage | $15,026 | 500 | 7.9% |
| Education | $366.28 | 10 | 0.2% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CALLIDITAS THERAPEUTICS US INC. | $56,642 | 89 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $50,909 | 99 | $0 (2024) |
| Travere Therapeutics, Inc. | $23,009 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17,563 | 20 | $0 (2024) |
| ANI Pharmaceuticals, Inc. | $17,248 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $14,179 | 89 | $0 (2024) |
| Horizon Therapeutics plc | $2,212 | 11 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $1,726 | 10 | $0 (2022) |
| Amgen Inc. | $675.47 | 32 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $672.06 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,354 | 139 | Mallinckrodt Hospital Products Inc. ($19,443) |
| 2023 | $82,319 | 175 | Calliditas Therapeutics US Inc. ($34,582) |
| 2022 | $57,041 | 116 | Mallinckrodt Hospital Products Inc. ($26,364) |
| 2021 | $2,988 | 58 | AstraZeneca Pharmaceuticals LP ($1,821) |
| 2020 | $2,141 | 33 | AstraZeneca Pharmaceuticals LP ($1,714) |
| 2019 | $1,727 | 66 | AstraZeneca Pharmaceuticals LP ($536.55) |
| 2018 | $1,628 | 68 | OPKO Pharmaceuticals, LLC ($395.72) |
| 2017 | $1,119 | 52 | OPKO Pharmaceuticals, LLC ($145.87) |
All Payment Transactions
707 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $810.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $169.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $126.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $341.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $299.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Catheter Lock Solution | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEPHROLOGY | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: NEPHROLOGY | ||||||
| 11/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Nephrology | ||||||
| 10/30/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Catheter Lock Solution | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $141.43 | General |
| 10/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $19.73 | General |
| Category: Endovascular | ||||||
| 09/20/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $427.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 465 | 5,570 | $519,719 | $128,925 |
| 2022 | 9 | 478 | 1,267 | $359,609 | $118,999 |
| 2021 | 14 | 692 | 18,765 | $774,935 | $239,032 |
| 2020 | 16 | 1,032 | 30,426 | $1.1M | $285,922 |
Total Patients
2,667
Total Services
56,028
Medicare Billing
$772,877
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 37 | 178 | $151,300 | $48,976 | 32.4% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 17 | 4,390 | $193,160 | $25,741 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 338 | $59,225 | $19,714 | 33.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 69 | $51,750 | $16,401 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 220 | $55,000 | $14,552 | 26.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 144 | $5,040 | $1,504 | 29.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,320 | $833.91 | 63.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 56 | $672.00 | $470.40 | 70.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $440.00 | $388.35 | 88.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 18 | 151 | $1,812 | $344.17 | 19.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 36 | 216 | $183,600 | $61,754 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 234 | 429 | $75,075 | $26,457 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 107 | 203 | $50,750 | $14,023 | 27.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 28 | 54 | $40,500 | $13,011 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 132 | $4,620 | $1,461 | 31.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 18 | $2,160 | $1,265 | 58.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $540.00 | $529.20 | 98.0% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 14 | 135 | $1,620 | $315.76 | 19.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 62 | $744.00 | $183.57 | 24.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 69 | 342 | $290,700 | $96,583 | 33.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 150 | 290 | $72,500 | $38,459 | 53.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 244 | 384 | $67,200 | $35,570 | 52.9% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 22 | 4,850 | $213,400 | $32,397 | 15.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 41 | 98 | $73,500 | $23,045 | 31.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 14 | 61 | $10,675 | $3,512 | 32.9% |
About Dr. Russell Silverstein, M.D
Dr. Russell Silverstein, M.D is a Nephrology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063483865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russell Silverstein, M.D has received a total of $190,316 in payments from pharmaceutical and medical device companies, with $41,354 received in 2024. These payments were reported across 707 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($69,055).
As a Medicare-enrolled provider, Silverstein has provided services to 2,667 Medicare beneficiaries, totaling 56,028 services with total Medicare billing of $772,877. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Dallas, TX
- Active Since 01/30/2006
- Last Updated 05/08/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1063483865
Products in Payments
- TARPEYO (Drug) $56,642
- ACTHAR (Biological) $51,351
- PURIFIED CORTROPHIN GEL (Drug) $17,312
- FARXIGA (Drug) $11,455
- KRYSTEXXA (Biological) $2,300
- LOKELMA (Drug) $955.19
- Kerendia (Drug) $598.71
- Rayaldee (Drug) $556.75
- Veltassa (Drug) $530.69
- JYNARQUE (Drug) $451.50
- INVOKANA (Drug) $435.57
- Velphoro (Drug) $421.91
- Parsabiv (Biological) $364.87
- LUPKYNIS (Drug) $299.65
- Auryxia (Drug) $245.12
- BENLYSTA (Biological) $224.40
- SOLIRIS (Drug) $203.45
- Rituxan (Biological) $172.68
- ULTOMIRIS (Biological) $156.03
- JARDIANCE (Drug) $153.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Dallas
Dr. Ankit Mehta, M.d, M.D
Nephrology — Payments: $907,733
Nephrology $907,733
Irfan Agha, M.d, M.D
Nephrology — Payments: $278,709
Nephrology $278,709
Robert Toto, Md, MD
Nephrology — Payments: $199,974
Nephrology $199,974
Christopher Hebert, Md, MD
Nephrology — Payments: $174,262
Nephrology $174,262
Dr. Sumit Kumar, M.d, M.D
Nephrology — Payments: $158,458
Nephrology $158,458
Dr. Samir Parikh, M.d, M.D
Nephrology — Payments: $76,733
Nephrology $76,733